These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38802118)

  • 1. Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
    Park IR; Moon JS
    Diabetes Metab J; 2024 May; 48(3):387-389. PubMed ID: 38802118
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease.
    Li M; Al-Sarraf A; Mattman A; Frohlich J
    BMJ Case Rep; 2012 Apr; 2012():. PubMed ID: 22604766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
    Bays HE; Davidson MH; Massaad R; Flaim D; Lowe RS; Tershakovec AM; Jones-Burton C
    Am J Cardiol; 2011 Aug; 108(4):523-30. PubMed ID: 21596364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Ju SH; Lim JY; Song M; Kim JM; Kang YE; Yi HS; Joung KH; Lee JH; Kim HJ; Ku BJ
    Front Endocrinol (Lausanne); 2024; 15():1336357. PubMed ID: 38586464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.
    Torimoto K; Okada Y; Mori H; Hajime M; Tanaka K; Kurozumi A; Narisawa M; Yamamoto S; Arao T; Matsuoka H; Inokuchi N; Tanaka Y
    Lipids Health Dis; 2013 Sep; 12():137. PubMed ID: 24053480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokines Levels in Patients With Coronary Artery Disease and Diabetes Mellitus].
    Koshel'skaia OA; Vinnitskaia IV; Konko TIu; Kravchenko ES; Suslova TE; Karpov RS
    Kardiologiia; 2015; 55(3):67-74. PubMed ID: 26320293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use.
    Reddy KJ; Singh M; Batsell RR; Bangit JR; Zaheer MS; John S; Varghese S; Molinella R
    J Clin Hypertens (Greenwich); 2009 Dec; 11(12):766-8. PubMed ID: 20021539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency.
    Viigimaa M; Vaverkova H; Farnier M; Averna M; Missault L; Hanson ME; Dong Q; Shah A; Brudi P
    Lipids Health Dis; 2010 Nov; 9():127. PubMed ID: 21050476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
    Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
    Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies.
    Kasmas SH; Izar MC; França CN; Ramos SC; Moreira FT; Helfenstein T; Moreno RA; Borges NC; Figueiredo-Neto AM; Fonseca FA
    Braz J Med Biol Res; 2012 Nov; 45(11):1095-101. PubMed ID: 22801416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?
    de Lorgeril M
    World Rev Nutr Diet; 2009; 100():80-89. PubMed ID: 19696530
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.
    Li L; Zhang M; Su F; Li Y; Shen Y; Shen J; Zhang D
    Lipids Health Dis; 2015 Feb; 14():10. PubMed ID: 25879728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism.
    Her AY; Kim JY; Kang SM; Choi D; Jang Y; Chung N; Manabe I; Lee SH
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):167-74. PubMed ID: 20147603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
    Catapano A; Brady WE; King TR; Palmisano J
    Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.
    Hong SJ; Jeong HS; Ahn JC; Cha DH; Won KH; Kim W; Cho SK; Kim SY; Yoo BS; Sung KC; Rha SW; Shin JH; Han KR; Chung WS; Hyon MS; Lee HC; Bae JH; Rhee MY; Kwan J; Jeon DW; Yoo KD; Kim HS
    Clin Ther; 2018 Feb; 40(2):226-241.e4. PubMed ID: 29402522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease.
    Masuda J; Tanigawa T; Yamada T; Nishimura Y; Sasou T; Nakata T; Sawai T; Fujimoto N; Dohi K; Miyahara M; Nishikawa M; Nakamura M; Ito M
    Int Heart J; 2015 May; 56(3):278-85. PubMed ID: 25902885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared to rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy.
    Vaverkova H; Farnier M; Averna M; Missault L; Viigimaa M; Dong Q; Shah A; Johnson-Levonas AO; Brudi P
    Cardiovasc Ther; 2012 Apr; 30(2):61-74. PubMed ID: 20626402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study.
    Sawayama Y; Maeda S; Ohnishi H; Hayashi S; Hayashi J
    Clin Drug Investig; 2010; 30(3):157-66. PubMed ID: 20155988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Dyslipidemia Control by Combination Therapy with Rosuvastatin 10 Mg and Ezetimibe 10 Mg Compared with Rosuvastatin 20 Mg Monotherapy in Patients with Chronic Coronary Syndromes: A Randomized, Single-blind Controlled Trial.
    Tran AV; Tran BLT; Bui NM; Le ATT; Nguyen DT; Tran SK; Ngo TH
    Cardiovasc Hematol Agents Med Chem; 2024; 22(3):390-398. PubMed ID: 38275031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.